Vetfarmas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 13,776,862 | 11,607,645 | 10,411,053 | 10,343,574 | 8,647,371 | 9,073,497 | 9,980,696 | 11,779,426 |
| Profit before tax | 273,598 | -165,630 | 164,995 | 59,116 | 350,450 | 254,062 | 497,644 | 567,330 |
| Net profit | 257,809 | -165,630 | 132,734 | 64,741 | 287,774 | 203,394 | 409,249 | 473,495 |
| Equity | 3,914,960 | 3,749,330 | 3,882,064 | 3,946,805 | 4,234,579 | 4,404,640 | 4,813,889 | 5,231,829 |
| Liabilities | 4,043,193 | 2,958,745 | 1,731,796 | 1,003,053 | 1,228,714 | 1,115,835 | 999,671 | 1,890,111 |
| Non-current assets | 1,328,302 | 615,023 | 1,420,451 | 1,436,489 | 1,339,577 | 1,193,858 | 1,165,716 | 2,310,145 |
| Current assets | 6,600,290 | 6,071,604 | 4,183,025 | 3,493,083 | 4,118,221 | 4,319,699 | 4,633,972 | 4,792,476 |
| Total assets | 7,928,592 | 6,686,627 | 5,603,476 | 4,929,572 | 5,457,798 | 5,513,557 | 5,799,688 | 7,102,621 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,841,638 | 1,885,006 | 2,580,841 |
| Social insurance contributions | - | - | - | - | - | 236,667 | 245,076 | 279,087 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -3.5% | -15.7% | -10.3% | -0.6% | -16.4% | +4.9% | +10.0% | +18.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.3% | -2.5% | 2.4% | 1.3% | 5.3% | 3.7% | 7.1% | 6.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.6% | -4.4% | 3.4% | 1.6% | 6.8% | 4.6% | 8.5% | 9.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.9% | -1.4% | 1.3% | 0.6% | 3.3% | 2.2% | 4.1% | 4.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.0% | -1.4% | 1.6% | 0.6% | 4.1% | 2.8% | 5.0% | 4.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 0.8 | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 252,786 | 223,942 | 207,529 | 206,527 | 227,065 | 259,861 | 302,445 | 334,960 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vetfarmas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-11 | 0.03 |
| 2026-04-20 | 2026-04-29 | 0.03 |
| 2024-05-16 | 2024-05-23 | 980.91 |
| 2022-11-21 | 2022-12-12 | 4.25 |
| 2022-11-17 | 2022-11-18 | 4.25 |
| 2022-10-31 | 2022-11-13 | 4.25 |
| 2022-07-18 | 2022-07-24 | 1584.29 |
| 2022-01-26 | 2022-02-01 | 0.62 |
Vetfarmas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-07 | 2026-08-13 | 0.06 |
| 2026-07-03 | 2026-07-07 | 0.06 |
| 2026-06-05 | 2026-06-05 | 211.52 |
| 2026-04-30 | 2026-05-03 | 62.66 |
| 2025-05-17 | 2025-05-20 | 13.34 |
| 2025-04-11 | 2025-04-23 | 399.53 |
| 2025-04-08 | 2025-04-10 | 48.57 |
| 2025-04-05 | 2025-04-07 | 148109.0 |
| 2025-04-02 | 2025-04-04 | 148157.57 |
| 2025-03-28 | 2025-04-01 | 148109.27 |
| 2025-03-20 | 2025-03-27 | 0.27 |
| 2025-01-30 | 2025-02-10 | 1184.61 |
| 2024-12-30 | 2025-01-28 | 141050.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vetfarmas, UAB (company code 158894285) is a Private Limited Liability Company engaged in the wholesale of grain, unmanufactured tobacco, seeds and animal feeds. In 2025, the company generated revenue of €11.78M, up 18.0% year on year and 29.8% over two years. Net profit reached €473.5K, compared with €409.2K in 2024 and €203.4K in 2023, showing a steady upward profit trend. The 2025 profit margin was 4.0%, broadly in line with the 4.1% margin in 2024 and above the 2.2% recorded in 2023. The balance sheet also expanded in 2025, with total assets rising to €7.10M from €5.80M a year earlier. Equity increased to €5.23M, while liabilities grew to €1.89M. The equity ratio stood at 73.7% and debt-to-equity at 0.36, indicating a conservative leverage profile. Return on equity was 9.1% and return on assets 6.7%. Asset turnover reached 1.66x. Revenue per employee was €336.6K and profit per employee €13.5K.